Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors [1] (multiple letters)

Journal of Clinical Oncology

Volumn 22, Issue 6, 2004, Pages 1158-1159

  Dubs, Adrian ^a   Jacky, Emanuel ^a   Stahel, Rolf ^a   Taverna, Christian ^a   Honegger, Hanspeter ^a   Motzer, Robert J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ABDOMINAL CRAMP; CANCER REGRESSION; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; GERM CELL TUMOR; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; LETTER; NEUROTOXICITY; OTOTOXICITY; PERCEPTION DEAFNESS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; TINNITUS; CHEMICALLY INDUCED DISORDER; NOTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ETOPOSIDE; GERMINOMA; HEARING LOSS; HUMANS;

EID: 1842614208     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.99.239     Document Type: Letter

References (0)